Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment in Taiwan, Hong Kong, the United Kingdom, and internationally. It operates through two segments: Prevention and Diagnostics. The company offers CircleDNA, a consumer genetic testing product to offer comprehensive DNA test. It also provides Insighta develops and commercializes multi-cancer early detection technology named Fragma. In addition, the company, through acquisition of ACT Genomics, which is involved in genomic profiling of panels through ACTOnco, ACT HRD, ACTFusion, and ACTDrug. Further, the company offers ACTLiquid Pro, an NGS-based liquid biopsy assay for pan-solid tumors; ACTMonitor which provides realtime monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk which manages the cancer risk. Prenetics Global Limited is based in Quarry Bay, Hong Kong.

Prenetics

Joel Neoh

Kuala Lumpur, Kuala Lumpur, Malaysia, Asia

Annouced Date	Organization Name	Funding Round	Money Raised
May 06, 2015	KFit	Seed Round - KFit	0
Nov 01, 2021	ULive	Pre Seed Round - ULive	0
Aug 29, 2022	Ejen2u	Angel Round - Ejen2u	0
Sep 18, 2023	Evo	Private Equity Round - Evo	2.8M

Joel Neoh

Founder and CEO

Joel Neoh has made 6 investments. Their Latest investment was Private Equity Round - Evo on Sep 18, 2023

Number of investment

Number of exits